精神医学杂志
精神醫學雜誌
정신의학잡지
JOURNAL OF PSYCHIATRY
2015年
3期
175-178
,共4页
李宏伟%高镇松%郭赛玲%吴强%黄佩珊%陈耿谊
李宏偉%高鎮鬆%郭賽玲%吳彊%黃珮珊%陳耿誼
리굉위%고진송%곽새령%오강%황패산%진경의
精神分裂症%HPA轴%自杀行为%皮质醇%神经内分泌
精神分裂癥%HPA軸%自殺行為%皮質醇%神經內分泌
정신분렬증%HPA축%자살행위%피질순%신경내분비
Schizophrenia%Hypothalamus-pituitary-adrenal axis%Suicide behavior%Cortisol%Neurocrine
目的:探讨精神分裂症患者下丘脑-垂体-肾上腺( HPA)轴释放功能与自杀行为的关系。方法对26例伴自杀行为(研究组)和28例不伴自杀行为(对照组)的精神分裂症患者,以电化学发光法测定血浆皮质醇和昼夜分泌节律,同步测定24 h尿17-羟皮质醇、24 h尿游离皮质酮、地塞米松抑制试验( DST),评估HPA轴释放功能,应用阳性和阴性综合征量表( PANSS)、汉密尔顿抑郁量表( HAMD-17)评定病情。常规抗精神病药治疗6周后复查所有检查项目及量表,并与25名健康者(健康组)对照。结果研究组血浆皮质醇浓度在治疗前后上午8点均高于健康组(P<0.05),也高于对照组(P<0.05),而对照组则与健康组比较差异无统计学意义(P>0.05)。研究组在治疗前后及治疗后下午8点和夜间0点血浆皮质醇浓度均低于其他采血时点(P<0.05)。对照组治疗前后夜间0点浓度低于其他采血时点(P<0.05)。两组的24 h尿游离皮质酮浓度在治疗前均高于治疗后(P<0.05),治疗前后研究组高于对照组(P<0.05)。研究组DST阳性率高于对照组(P<0.05)。出院后半年研究组再次自杀率高于对照组(P<0.05)。结论伴自杀行为的精神分裂症患者存在HPA轴功能过度释放现象。
目的:探討精神分裂癥患者下丘腦-垂體-腎上腺( HPA)軸釋放功能與自殺行為的關繫。方法對26例伴自殺行為(研究組)和28例不伴自殺行為(對照組)的精神分裂癥患者,以電化學髮光法測定血漿皮質醇和晝夜分泌節律,同步測定24 h尿17-羥皮質醇、24 h尿遊離皮質酮、地塞米鬆抑製試驗( DST),評估HPA軸釋放功能,應用暘性和陰性綜閤徵量錶( PANSS)、漢密爾頓抑鬱量錶( HAMD-17)評定病情。常規抗精神病藥治療6週後複查所有檢查項目及量錶,併與25名健康者(健康組)對照。結果研究組血漿皮質醇濃度在治療前後上午8點均高于健康組(P<0.05),也高于對照組(P<0.05),而對照組則與健康組比較差異無統計學意義(P>0.05)。研究組在治療前後及治療後下午8點和夜間0點血漿皮質醇濃度均低于其他採血時點(P<0.05)。對照組治療前後夜間0點濃度低于其他採血時點(P<0.05)。兩組的24 h尿遊離皮質酮濃度在治療前均高于治療後(P<0.05),治療前後研究組高于對照組(P<0.05)。研究組DST暘性率高于對照組(P<0.05)。齣院後半年研究組再次自殺率高于對照組(P<0.05)。結論伴自殺行為的精神分裂癥患者存在HPA軸功能過度釋放現象。
목적:탐토정신분렬증환자하구뇌-수체-신상선( HPA)축석방공능여자살행위적관계。방법대26례반자살행위(연구조)화28례불반자살행위(대조조)적정신분렬증환자,이전화학발광법측정혈장피질순화주야분비절률,동보측정24 h뇨17-간피질순、24 h뇨유리피질동、지새미송억제시험( DST),평고HPA축석방공능,응용양성화음성종합정량표( PANSS)、한밀이돈억욱량표( HAMD-17)평정병정。상규항정신병약치료6주후복사소유검사항목급량표,병여25명건강자(건강조)대조。결과연구조혈장피질순농도재치료전후상오8점균고우건강조(P<0.05),야고우대조조(P<0.05),이대조조칙여건강조비교차이무통계학의의(P>0.05)。연구조재치료전후급치료후하오8점화야간0점혈장피질순농도균저우기타채혈시점(P<0.05)。대조조치료전후야간0점농도저우기타채혈시점(P<0.05)。량조적24 h뇨유리피질동농도재치료전균고우치료후(P<0.05),치료전후연구조고우대조조(P<0.05)。연구조DST양성솔고우대조조(P<0.05)。출원후반년연구조재차자살솔고우대조조(P<0.05)。결론반자살행위적정신분렬증환자존재HPA축공능과도석방현상。
Objective To explore the correlations between the release function of hypothalamus-pituitary-adrenal ( HPA) axis and the suicide behaviors in patients with schizophrenia.Methods A total of 26 schizophrenic patients with suicide behavior in study group and 28 schizophrenic patients without suicide behavior in control group were tested with electrochemistry luminescence for plasma cortisol and morning-night secretion rhythm, and with 24 h urine 17-OH cortisol, 24 h urine free corticosterone, dexamethasone suppression test ( DST) for the release function of HPA axis in two groups.The two groups were assessed with the Positive and Negative Symptom Scale (PANSS) and Hamilton Depression Scale (HAMD-17) for the symptoms of the patients.After 6 weeks treatment of anti-psychotic drug, the two groups were tested and assessed with all examination and scales once more and the results of examinations were compared with those of 25 healthy people in health group.Results The plasma cortisol level in the study group before and after treatment were all significantly higher than those in healthy group ( P<0.05)and control group(P<0.05), but there was no difference between control group and healthy group(P>0.05).Before and after treatment, the plasma cortisol level in the study group at 0AM and 8PM were all significantly lower than those at other time point(P<0.05), but in control group at 0AM was significantly lower than those at other time point(P<0.05).The 24 h urine free corticosterone in two groups before treatment were all significantly higher than those after treatment(P<0.05), and the 24 h urine free corticosterone in study group before and after treatment were all significantly higher than those in control group( P<0.05).The positive rates of DST in study group were significantly higher than those in control group(P<0.05).After 6 months, the rates of relapse suicide in study group were significantly higher than those in control group( P>0.05) .Conclussion There is extent over-release function of HPA axis in patients with schizophrenia.